Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA “Chief Messaging Officer” Pitts Will Centralize Agency Communications

This article was originally published in The Tan Sheet

Executive Summary

FDA Associate Commissioner for External Relations Peter Pitts will coordinate FDA's communications within the commissioner's office and across the agency's centers

You may also be interested in...



FDA “Strategic Plan” Team Takes Shape: McClellan Names Senior Advisors

FDA Senior Economic Advisor Tomas Philipson, PhD, will work with Commissioner Mark McClellan, MD/PhD, to develop strategic initiatives

People In Brief

CHPA elections: Bayer Consumer Care North America Senior VP & Region Head Timothy Hayes named chairman-elect during association's annual conference in Aventura, Fla. March 13-15. He will succeed current chairman and Blistex President & COO Richard Green in 2004. Hayes was elected to CHPA's board in 2000; he joined its executive committee and chaired its finance committee the same year. Members elected to the trade group's board for the first time include Leiner Health Products President Gale Bensussen, Pfizer Consumer Healthcare North America President Gordon Knapp, P&G Global Personal Health Care VP Mary Lynn Ferguson-McHugh, Shaklee Senior VP & General Counsel Marjorie Fine...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel